XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026

XORTX Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Equivalents
0.990.250.861.191.061.92.472.33.083.843.455.076.167.9110.438.8610.4212.4214.93.95
Cash & Short-Term Investments
0.990.250.861.191.061.92.472.33.083.843.455.076.167.9110.438.8610.4212.4214.93.95
Cash Growth (YoY)
-6.53%-86.80%-65.05%-48.11%-65.45%-50.59%-28.25%-54.61%-50.06%-51.50%-66.96%-42.77%-40.84%-36.34%-29.95%124.08%150.73%158.55%10982.39%2685.04%
Other Receivables
0.090.060.080.020.010.020.020.010.020.030.060.070.030.040.080.060.190.120.040.02
Receivables
0.090.060.080.020.010.020.020.010.020.030.060.070.030.040.080.060.190.120.040.02
Prepaid Expenses
1.350.050.020.030.10.190.180.10.210.640.240.090.180.260.380.070.270.560.440.1
Other Current Assets
-0.370.290.110.09-0-0.050.160.32--0.01-0.45-0.180.561.94
Total Current Assets
2.440.741.261.361.262.12.682.413.364.664.075.236.388.2110.99.4310.8813.2815.946
Property, Plant & Equipment
-0.010.040.060.080.020.030.050.070.020.020.040.060.080.090.10.13---
Other Intangible Assets
2.550.190.190.190.20.180.180.190.170.170.180.170.160.170.20.190.20.20.20.19
Other Long-Term Assets
1.21.21.21.21.21.21.21.21.21.21.21.21.21.21.191.171.251.291.27-
Total Assets
6.182.142.682.812.743.54.093.854.86.055.476.647.89.6612.3710.912.4614.7717.416.19

Liabilities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Accounts Payable
0.560.560.40.480.360.350.080.110.270.190.20.390.240.421.290.970.580.590.320.51
Accrued Expenses
0.120.290.160.20.10.060.060.220.170.140.090.130.120.120.150.380.130.10.230.06
Current Portion of Leases
-0.020.040.060.080.020.040.060.080.010.010.030.050.060.070.060.07---
Other Current Liabilities
000.010.10.180.330.571.331.57-0.53--------8.98
Total Current Liabilities
0.680.860.60.840.710.760.761.722.090.340.830.550.40.61.511.420.770.690.559.55
Long-Term Leases
--------------0.010.030.05---
Other Long-Term Liabilities
---------3.22----3.851.652.133.353.63-
Total Liabilities
0.680.860.60.840.710.760.761.722.093.560.830.550.40.65.383.12.954.044.199.55

Shareholders' Equity

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Common Stock
20.820.1820.1819.4918.9118.9118.4917.8717.8717.8717.0617.0617.0617.0616.5214.5715.5316.0315.8110.33
Retained Earnings
-26.32-24.63-23.82-23.23-22.58-21.87-21.17-21.29-20.7-20.87-17.85-20.55-19.22-17.53-15.7-11.84-11.41-10.5-7.66-14.86
Comprehensive Income & Other
11.025.735.735.725.75.76.015.555.545.495.449.589.569.536.175.075.385.215.071.18
Shareholders' Equity
5.51.282.081.972.032.743.342.132.72.494.646.097.49.0677.89.5110.7313.23-3.35
Total Liabilities & Equity
6.182.142.682.812.743.54.093.854.86.055.476.647.89.6612.3710.912.4614.7717.416.19

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Total Debt
-0.020.040.060.080.020.040.060.080.010.010.030.050.060.080.090.11---
Net Cash (Debt)
0.990.240.831.130.981.882.432.242.993.823.445.046.127.8510.368.7610.312.4214.93.95
Net Cash Growth (YoY)
1.12%-87.49%-66.03%-49.32%-67.18%-50.81%-29.14%-55.58%-51.06%-51.30%-66.82%-42.49%-40.62%-36.83%-30.48%121.75%147.98%158.55%10982.39%2685.04%
Net Cash Per Share
0.610.170.631.171.302.513.723.865.167.878.5912.6115.3120.3332.5730.3635.7043.0454.2118.92
Filing Date Shares Outstanding
1.821.391.391.391.040.760.760.640.580.580.580.40.40.40.40.320.290.290.290.29
Total Common Shares Outstanding
1.731.391.391.040.760.760.70.580.580.580.40.40.40.40.330.290.290.290.290.21
Working Capital
1.76-0.120.660.520.551.351.920.691.264.323.244.675.977.619.388.0210.1112.615.39-3.55
Book Value Per Share
3.180.921.501.892.683.624.793.674.664.2911.6115.2218.5122.6620.9527.0232.9337.1845.82-15.83
Tangible Book Value
2.961.11.91.781.842.563.151.952.542.334.475.917.248.896.87.619.3110.5313.02-3.55
Tangible Book Value Per Share
1.710.791.361.712.423.384.533.354.374.0011.1714.8018.1022.2420.3526.3632.2436.4845.12-16.74
Machinery
0.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.010.01---
SEC Filings: 10-K · 10-Q